Literature DB >> 28962210

Three sporadic cases of Creutzfeldt-Jakob disease in China and their clinical analysis.

Xingbang Wang1, Na Li2, Aifen Liu1, Lin Ma1, Peiyan Shan1, Wenjing Jiang1, Qun Zhang1.   

Abstract

The present study described the characteristics of three cases of Creutzfeldt-Jakob disease (CJD) in China and analyzed their clinical presentations. The clinical information of the three cases was collected and analyzed. Blood and cerebrospinal fluid (CSF) specimens of the patients were collected for detection of the prion protein (PRNP) gene and 14-3-3 protein levels. Dynamic changes of electroencephalograms (EEGs) and brain magnetic resonance images (MRIs) were also observed. All the three cases were sporadic CJD cases. They presented with symptoms including hyposthenia, progressive memory loss, truncal and limb ataxia, dysarthria, lowered vision acuity, bucking, language disorders, myoclonia and akinetic mutism state. One of the three cases was associated with a prolonged duration of >6 years. The EEG of two cases showed slow biphasic waves. The diffusion-weighted MRI sequence revealed abnormal hyperintensity and bilateral ribboning in the cortex. Two patients tested positive for the 14-3-3 protein in the CSF. All patients were of methionine homozygosity at codon 129 in the gene encoding PRNP protein and one patient had a mutation. The CJD cases showed differences in terms of symptoms and disease duration. Subacute onset was common and with attentive nursing and supportive treatments, one of the patients had a prolonged survival time of >6 years.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; clinical analysis; clinical diagnosis; duration; sporadic

Year:  2017        PMID: 28962210      PMCID: PMC5609245          DOI: 10.3892/etm.2017.4832

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

1.  Creutzfeldt-Jakob disease: case discussion and imaging review.

Authors:  Cory Morgan; Manu Gupta; Waleed El-Feky; Sadat Shamim; Michael Opatowsky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-01

2.  Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Taim Muayqil; Gary Gronseth; Richard Camicioli
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

3.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.

Authors:  André Karch; Peter Hermann; Claudia Ponto; Matthias Schmitz; Amandeep Arora; Saima Zafar; Franc Llorens; Annika Müller-Heine; Inga Zerr
Journal:  Neurobiol Aging       Date:  2015-02-07       Impact factor: 4.673

5.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  P Sanchez-Juan; A Green; A Ladogana; N Cuadrado-Corrales; R Sáanchez-Valle; E Mitrováa; K Stoeck; T Sklaviadis; J Kulczycki; K Hess; M Bodemer; D Slivarichová; A Saiz; M Calero; L Ingrosso; R Knight; A C J W Janssens; C M van Duijn; I Zerr
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

Review 6.  Creutzfeldt-Jakob disease.

Authors:  Beata Sikorska; Richard Knight; James W Ironside; Paweł P Liberski
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.

Authors:  Catherine Pennington; Gurjit Chohan; Jan Mackenzie; Mary Andrews; Robert Will; Richard Knight; Alison Green
Journal:  Neurosci Lett       Date:  2009-03-05       Impact factor: 3.046

8.  Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.

Authors:  Brian S Appleby; Kristin K Appleby; Barbara J Crain; Chiadi U Onyike; Mitchell T Wallin; Peter V Rabins
Journal:  Arch Neurol       Date:  2009-02

9.  Striatal [123I] FP-CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt-Jakob disease.

Authors:  M Ragno; M G Scarcella; G Cacchiò; S Capellari; F Di Marzio; P Parchi; L Trojano
Journal:  Acta Neurol Scand       Date:  2008-07-13       Impact factor: 3.209

Review 10.  Review: Laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease.

Authors:  Jeongmin Lee; Jae Wook Hyeon; Su Yeon Kim; Kyu-Jam Hwang; Young Ran Ju; Chongsuk Ryou
Journal:  J Med Virol       Date:  2014-06-30       Impact factor: 2.327

View more
  1 in total

1.  Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.

Authors:  Unekwu M Yakubu; Celso S G Catumbela; Rodrigo Morales; Kevin A Morano
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.